Analysts reported that Mexico“s Vitro company will continue its strategy of reducing working capital by US$ 50 million and sales costs by US$ 25 million. The sale of Anchor Glass in February this y…
Analysts reported that Mexico“s Vitro company will continue its strategy of reducing working capital by US$ 50 million and sales costs by US$ 25 million. The sale of Anchor Glass in February this year and the dropping of the value of Serfin stocks negatively affected the net results of Vitro at the close of last year, they added, but claimed that such things would not happen again, and 1997 should show better results. The Vitro bottling company has a future reserve amount of US$ 15 million for any stock drops, and Vitro nominative shares have reached 23.75 pesos per share.